StockWatch
·

Valiant Laboratories Ltd Q3 FY25 Results

VALIANTLABQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue35.2364.0%
Total Income36.8148.2%
Expenditure35.1922.4%
PBT1.62141.4%
Net Profit2.35149.5%
OPM-1.54%34.73pp
NPM6.37%25.46pp
EPS0.54149.5%
View full financials

Informational and educational content only. Not investment advice.